§ Mr. Connarty
To ask the Secretary of State for Health whether recombinant treatment products will be made available this year to all haemophilia sufferers in(a) England and (b) Northern Ireland. 
§ Ms Blears
In England, all haemophilia patients up to the age of 21 years receive recombinant clotting factors. The Government are considering the case for extending provision to all other haemophilia patients. A decision will be made shortly.
Recombinant clotting factors have recently been made available for all haemophilia patients in Northern Ireland.